Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Vermilion Energy Inc (VET)?

Page 1 of 2

Is Vermilion Energy Inc (NYSE:VET) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research on it. Given their 2 and 20 payment structure, hedge funds have more resources than the average investor. The funds have access to expert networks and get tips from industry insiders. They also have numerous Ivy League graduates and MBAs. Like everyone else, hedge funds perform miserably at times, but their consensus picks have historically outperformed the market after risk adjustments.

Vermilion Energy Inc (NYSE:VET) investors should be aware of a decrease in enthusiasm from smart money in recent months, which should not come as a surprise, as the shares of the company were down 25.56% during the third quarter. Vermilion Energy Inc (NYSE:VET) was in 6 hedge funds’ portfolios at the end of the third quarter of 2015.  There were 8 hedge funds in our database with Vermilion Energy Inc (NYSE:VET) positions at the end of the previous quarter. A slightly bullish outlook from the hedgies prompted us to find out more about the hedge funds holding positions in the company.

For an in-depth understanding of hedge fund behavior towards the market, we will also compare Vermilion Energy Inc (NYSE:VET) to other stocks, including Equity Commonwealth (NYSE:EQC), Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL), and Office Depot Inc (NASDAQ:ODP) to get a better sense of its popularity.

If you’d ask most shareholders, hedge funds are perceived as underperforming, old financial tools of yesteryear. While there are greater than 8000 funds trading at present, Our researchers look at the leaders of this group, about 700 funds. These investment experts orchestrate bulk of the smart money’s total asset base, and by watching their top equity investments, Insider Monkey has unearthed numerous investment strategies that have historically outperformed the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy beat the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

Keeping this in mind, we’re going to take a peek at the new action regarding Vermilion Energy Inc (NYSE:VET).

How have hedgies been trading Vermilion Energy Inc (NYSE:VET)?

At the end of the third quarter, a total of 6 of the hedge funds tracked by Insider Monkey were long this stock, a decline of 25% from one quarter earlier. With hedge funds’ capital changing hands, there exists a select group of notable hedge fund managers who were upping their stakes substantially (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, BlueCrest Capital Mgmt., managed by Michael Platt and William Reeves, holds the biggest position in Vermilion Energy Inc (NYSE:VET). BlueCrest Capital Mgmt. has a $4.3 million position in the stock, comprising 0.1% of its 13F portfolio. On BlueCrest Capital Mgmt.’s heels is Lucas Capital Management, managed by Russell Lucas, which holds a $1.6 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Remaining members of the smart money that are bullish encompass Cliff Asness’ AQR Capital Management, Renaissance Technologies, and Israel Englander’s Millennium Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!